Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cmate Blood Glucose Analyzer: Clinical Comparison Study of Fasting Blood Glucose Levels in the Morning

NCT07088497 is registered in ClinicalTrials.gov with Revlis Biotech Company Limited as lead sponsor.

NCT NCT07088497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cmate Blood Glucose Analyzer: Clinical Comparison Study of Fasting Blood Glucose Levels in the Morning
Lead sponsor
Revlis Biotech Company Limited
Phase
Observational
Overall status
Completed
Start date
July 21, 2025
Completion date
October 30, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, glucose